Menu
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Comprehensive Services
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Comprehensive Services
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
News

Your Trusted CRO Partner for Controlled Substance Studies

Posted on November 25, 2024 by Dipesh Chodvadia

Read More

Accelerate your Phase-1 Clinical Trials With Novum

Posted on August 20, 2024 by Dipesh Chodvadia

Read More

From Complexity to Clarity: Enhancing Drug Administration with Human Factors Studies

Posted on July 26, 2024 by Dipesh Chodvadia

Read More

Ensuring Accuracy in Self-Administration Studies: Novum’s Approach to Success

Posted on July 25, 2024 by Dipesh Chodvadia

Read More

Empowering Biotech and Pharma: The Vital Role of Full-service CROs

The Vital Role of Full-Service CROs for Biotech and Pharma

Posted on June 13, 2024 by Dipesh Chodvadia

Read More

Exploring the Evolving Landscape of Ophthalmology Clinical Development

Ophthalmology-clinical-trials-CRO

Posted on May 15, 2024 by Dipesh Chodvadia

Read More

Challenges and Innovations in Patient PK Studies: What Lies Ahead

Posted on January 23, 2024 by Dipesh Chodvadia

Read More

Clovibactin – New antibiotic with Reduced Risk of Bacterial Resistance

Posted on November 2, 2023 by Dipesh Chodvadia

Read More

Clovibactin (Novo29): A Groundbreaking Discovery of a Highly Effective Novel Antibiotic with Lower Risk of Bacterial Resistance

Posted on August 31, 2023 by Dipesh Chodvadia

Read More

EMA Updates the PRIME Pathway with Roadmaps

Posted on April 13, 2023 by Dipesh Chodvadia

Read More

Posts navigation

Older posts

Categories

  • Blogs
  • Clinical Research Insights
  • Events & Conferences
  • Industry News
  • Novum News
  • Uncategorized

Archives

Tags

  • Industry Updates
  • ANDA
  • Pilot Program
  • FDA
  • BIO US
  • Dermatology
  • Self Administration Studies
  • CPHI
  • Clinical Trials
  • Ophthalmology
  • AAD Annual Meeting 2026

USA

Novum Pharmaceutical Research Services
3760 Pecos McLeod
Las Vegas, NV 89121 USA

Phone:

7024353902

SPAIN

Novum Therapeutics S.L.
World Trade Center, Moll de Barcelona, s/n, Edifici Est, 6º Planta
Barcelona, 08039 Spain

Email:

© 2026, Novum Pharmaceutical Research Services | Top CRO | USA | Canada | UK | Spain | India. All rights reserved.Privacy Policy

Site by Imagebox

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.